Aclaris Therapeutics Inc

ACRS remains in a Stage 2 advancing structure with persistent higher highs and higher lows supporting a medium-term bullish bias. Price has pulled back into the rising 9 EMA and 21 EMA confluence zone, offering a structurally sound entry. Although the active Bullish Exhaustion pattern at multi-month highs and extreme overbought readings warn of potential deeper pullbacks, EMAs continue to act as support. We will engage now, participating in the pullback interaction ahead of any further upside continuation.

• ↑12-month positive price momentum indicates strong investor sentiment
• ↑High institutional 13F ownership signals hedge fund confidence
• ↓Phase 2A ATI-450 trial efficacy fell short, hurting confidence